Nerinetide is under clinical development by NoNO and currently in Phase III for Acute Ischemic Stroke. According to GlobalData, Phase III drugs for Acute Ischemic Stroke have a 13% phase transition ...
Elezanumab (ABT-555) is under development for the treatment of acute ischemic stroke, acute traumatic cervical spinal cord injury and Cerebral infarction. It is administered as an intravenous infusion ...